Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal110d agoneutral
Novo Nordisk Files Deceptive Advertising Lawsuit Against Rival Eli LillyThe Wall Street Journal110d agoneutral
Novo Nordisk Files Deceptive Advertising Lawsuit Against Rival Eli LillyReuters110d agoneutral
Novo Nordisk says it is suing Eli Lilly, accusing it of false advertisingFinancial Times110d agoneutral
Novo Nordisk accuses Eli Lilly of deceptive marketing in weight-loss fightGuruFocus.com111d agoneutral
Scribe Therapeutics Files $107.2 Million IPO as Sanofi Backs Share PurchaseBloomberg111d agoneutral
‘Wild West’ of Untested Peptides Has Americans Paying in Crypto to Get Their FixSimply Wall St.113d agoneutral
Eli Lilly (LLY) Stock Looks Undervalued On Fair Value Yet Full On EarningsThe Wall Street Journal117d agoneutral
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’sInvestor's Business Daily124d agoneutral
Eli Lilly's Market Cap Balloons Again On This IPO's SetbackSimply Wall St.127d agoneutral
Eli Lilly (LLY) Stock May Trade At A Cash Flow Discount But An Earnings PremiumThe Wall Street Journal129d agoneutral
Why Medicare Isn’t a Game Changer for Weight-Loss Drugmakers